Antihistamine Physicochemical properties Instruction Precaution Adverse reaction
ChemicalBook > CAS DataBase List > Pizotifen

Pizotifen

Antihistamine Physicochemical properties Instruction Precaution Adverse reaction
Product Name
Pizotifen
CAS No.
15574-96-6
Chemical Name
Pizotifen
Synonyms
Litec;bc105;BC 105;PIZOTIFEN;Pizotifan;Pizotylene;Pizotyline;Pizotifenum;Sandomigram;Sandomigran
CBNumber
CB4230373
Molecular Formula
C19H21NS
Formula Weight
295.44
MOL File
15574-96-6.mol
More
Less

Pizotifen Property

Melting point:
140-142°C
Boiling point:
436.7±45.0 °C(Predicted)
Density 
1.164±0.06 g/cm3(Predicted)
storage temp. 
room temp
solubility 
DMSO: ≥8mg/mL
pka
pKa 6.95 (Uncertain)
form 
powder
color 
White to Off-White
Merck 
14,7515
CAS DataBase Reference
15574-96-6(CAS DataBase Reference)
NIST Chemistry Reference
Pizotyline(15574-96-6)
More
Less

Safety

Hazard Codes 
Xi,Xn
Risk Statements 
36/37/38-22-63
Safety Statements 
26-37/39-36/37
WGK Germany 
3
RTECS 
TM7165000
HS Code 
2934.99.3000
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H361Suspected of damaging fertility or the unborn child

Precautionary statements

P201Obtain special instructions before use.

P308+P313IF exposed or concerned: Get medical advice/attention.

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
B9688
Product name
Pizotifen
Purity
≥98% (HPLC)
Packaging
10mg
Price
$98.5
Updated
2024/03/01
Sigma-Aldrich
Product number
B9688
Product name
Pizotifen
Purity
≥98% (HPLC)
Packaging
50mg
Price
$390
Updated
2024/03/01
TCI Chemical
Product number
P2344
Product name
Pizotifen
Purity
>98.0%(HPLC)
Packaging
50mg
Price
$42
Updated
2021/12/16
TCI Chemical
Product number
P2344
Product name
Pizotifen
Purity
>98.0%(HPLC)
Packaging
200mg
Price
$109
Updated
2024/03/01
TRC
Product number
P552800
Product name
Pizotyline
Packaging
50mg
Price
$65
Updated
2021/12/16
More
Less

Pizotifen Chemical Properties,Usage,Production

Antihistamine

Pizotyline is also referred to as pizotifene and pizotifen malate. It is a chemical synthetic antihistamine. Its chemical structure is similar to that of heptaidime and amitriptyline. It has a strong anti 5serotonin and antihistamine effect and weak anti acetylcholine action, which is one of the commonly used drugs to prevent migraine. This product also inhibits the analgesic effect of bradykinin (BK) on the peripheral nerve and its sedative and antidepressant effects. This product can reduce the tolerance to ethanol, and can strengthen the effect of diazepam, sedative and tricyclic antidepressant. It is clinically used in typical and atypical migraine. It can reduce symptoms, reduce the number of episodes and duration, and the effect is significant. But it has no immediate effect on the acute attack of migraine. It can be used in erythromelalgia, angioedema, chronic urticaria, skin scratch disease etc.. It has also been reported that pizotyline can be used for the treatment of the carcinoid syndrome caused diarrhea, facial flushing and carotid artery pain as well as polycythemia induced pruritus.

Physicochemical properties

It is white needle like crystal, odorless, with bitter taste. The melting point is 147.5 151.5 centigrade. It can dissolve in organic solvent or acid solution, such as ethanol, chloroform, etc., insoluble in water. Pizotyline is synthesized by the multistep reaction using 2chloromethyl thiophene as raw material. It's an analgesic and mainly used for the treatment of typical and atypical migraine. It can also be used for chronic urticaria, atrial and ventricular premature beat.

Instruction

  • The drug is of small toxicity and can be used for a long-term; After six months of continuous medication, the patients can stop the use to observe the effect of this drug and avoid the accumulation of drugs in the body.
  • Attention should be paid to change of blood image in long term use.
  • Pizotyline can not be used in combination with monoamine oxidase inhibitors.

Precaution

  • This product can cause lethargy, fatigue, increased appetite, and weight gain with rare nausea, dizziness, flushing, muscle pain, etc.. Generally, they are common in the beginning medication of 1~2 weeks, and they will gradually reduce or disappear in the continued medication.
  • It is prohibited for patients with angle closure glaucoma or prostate hypertrophy dysuria
  • Motor vehicle drivers and high-altitude operations should be cautious to take pizotyline following the instructions of doctors.

Adverse reaction

  • Drowsiness and hyperactivity: somnolence is commonly seen within 1~2 weeks of starting medication, and it can gradually decrease or disappear after taking medicine, and the body weight gradually stabilizes after 6 months. The driver, the air operator should be cautious in the drug taking.
  • Other side effects: muscle soreness or painful spasms, restless legs, fluid retention, mild headache, vertigo, flushing, low sexual desire, exacerbation of epilepsy, dreaminess, palpitation, rash, menstrual disorder, insomnia and leukocyte decline.
  • Anticholinergic action: it is forbidden for patients with glaucoma, prostatic hypertrophy and pregnant women. In addition, patients with long-term use of pizotifen should pay attention to changes in blood.

Chemical Properties

White to Off-White Solid

Originator

Sandomigran ,Sandoz ,Italy ,1972

Uses

benzocycloheptane based drug

Uses

Serotonin antagonist structurally related to Cyproheptadine. Antimigraine; appetite stimulant.

Indications

Pizotifen, a potent antihistamine and antiserotonin agent usually prescribed for migraine prophylaxis, has had reported success in patients with polycythemia vera.

Definition

ChEBI: A benzocycloheptathiophene that is 9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophene 4-ylidene)-1-methylpiperidine which is joined from the 4 position to the 4 position of an N-methylpiperidine moiety b a double bond. It is a sedating antihistamine, with strong serotonin antagonist and weak antimuscarinic activity. It is generally used as the malate salt for the treatment of migraine and the prevention of headache attacks during cluster periods.

Manufacturing Process

(A) Preparation of Thenylidene-(2)-Phthalide: 24.2 g of thienyl-(2)-acetic acid, 52.0 g of phthalic acid anhydride, 4.0 g of anhydrous sodium acetate and 125 ml of 1-methylpyrrolidone-(2) are heated while stirring in an open flask for 3 hours to 205° to 208°C, while nitrogen is passed through. It is then cooled and the viscous reaction mixture poured into 1 liter of water. The precipitated substance is filtered off, washed with water and then dissolved in 200 ml of chloroform. After filtering off some undissolved substance, shaking is effected twice with 100 ml of 2 N sodium carbonate solution and then with water, drying is then carried out over sodium sulfate and the volume is reduced by evaporation. The crude phthalide is repeatedly recrystallized from ethanol, while treating with animal charcoal. It melts at 114° to 115°C.
(B) Preparation of o-[2-Thienyl-(2')-Ethyl]Benzoic Acid: 24.0 g of thenylidene(2)-phthalide, 8.8 g of red pulverized phosphorus, 240 ml of hydrochloric acid (d = 1.7) and 240 ml of glacial acetic acid are heated to boiling under nitrogen and while stirring vigorously. 70 ml toluene are then added and 6.0 g of red phosphorus added in small portions over a period of 1 hour. It is then poured into 3 liters of ice water, stirred with 300 ml of chloroform and the phosphorus removed by filtration.
The chloroform phase is then removed, the aqueous phase extracted twice more with 200 ml of chloroform and the united extracts shaken out 4 times,each time with 200 ml of 2 N sodium hydroxide solution. The alkaline solution is then rendered acid to Congo red reagent, using hydrochloric acid and extracted 3 times with chloroform. After drying over sodium sulfate and evaporating the solvent, the residue is chromatographed on aluminum oxide (Activity Stage V). The substance eluted with benzene and benzene/chloroform (1:1) is recrystallized from chloroform/hexane (1:1); MP 107° to 109°C.
(C) Preparation of 9,10-Dihydro-4H-Benzo[4,5]Cyclohepta[1,2-b]Thiophen(4)-One: 200 ml of 85% phosphoric acid and 112 g of phosphorus pentoxide are heated to 135°C. 7.0 g of o-[2-thienyl-(2')-ethyl]benzoic acid are then introduced while stirring thoroughly over a period of 30 min. Stirring is then continued for another hour at 135°C and the reaction mixture is then stirred into 1 liter of ice water. Extraction is then effected 3 times, using 250 ml ether portions, the ethereal extract is washed with 2 N sodium carbonate solution, dried over sodium sulfate and reduced in volume by evaporation. The residue is boiled up with 55 ml of ethanol, the solution freed of resin by decanting and then stirred at room temperature for 6 hours with animal charcoal. It is then filtered off, reduced in volume in a vacuum and the residue distilled. BP 120° to 124°C/0.005 mm, nD24.5 = 1.6559.
(D) Preparation of 4-[1'-Methyl-Piperidyl-(4')]-9,10-Dihydro-4HBenzo[4,5]Cyclohepta[1,2b]Thiophen-(4)-ol: 0.94 g of magnesium filings which have been activated with iodine are covered with a layer of absolute tetrahydrofuran and etched with a few drops of ethylene bromide. A solution of 5.0 g of 1-methyl-4-chloropiperidine in 5 ml of tetrahydrofuran is then added dropwise and boiling then effected for a further hour under reflux. After cooling to room temperature, the solution of 4.5 g of 9,10-dihydro-4Hbenzo[4,5]cyclohepta[1,2-b]thiophen-(4)-one in 5 ml of tetrahydrofuran is added dropwise.
Stirring is carried out first for 3 hours at room temperature and then for 2 hours at boiling temperature, it is then cooled and poured into 300 ml of icecold 20% ammonium chloride solution. It is then shaken out with methylene chloride, the methylene chloride solution washed with water and shaken 3 times with 30 ml portions of aqueous 2 N tartaric acid solution. The tartaric acid extract is rendered alkaline while cooling thoroughly and then extracted twice with methylene chloride. After washing with water, drying over potassium carbonate and reducing in volume by evaporation, the residue is recrystallized from ethanol. MP 197° to 199°C.
(E) Preparation of 4-[1'-Methyl-Piperidylidene-(4')]-9,10-Dihydro-4HBenzo[4,5]Cyclohepta[1,2-b]Thiophene Hydrochloride: 2 g of 4-[1'-methylpiperidyl-(4')]-9,10-dihydro4H-benzo[4,5]cyclohepta[1,2-b]thiophen-(4)-ol, 60 ml of glacial acetic acid and 20 ml of concentrated hydrochloric acid are boiled for 30 minutes under reflux. After evaporating in a vacuum, the residue is triturated with 3 ml of acetone, the precipitated hydrochloride is then filtered off and it is recrystallized from isopropanol/ether. MP 261° to 263°C (decomposition).

brand name

Sandomigran (Novartis).

Therapeutic Function

Migraine therapy

Biochem/physiol Actions

Pizotifen is a serotonin antagonist acting mainly at the 5-HT1, 5-HT2A and 5HT2C receptors with some antihistamine activity. It is used for the prevention of vascular headache including migraine and cluster headache.

Clinical Use

Prophylactic treatment of vascular headaches including migraine

Drug interactions

Potentially hazardous interactions with other drugs
Adrenergic neurone blockers: pizotifen antagonises hypotensive effect.

Metabolism

Pizotifen undergoes extensive metabolism.
Over half of a dose is excreted in the urine, chiefly as metabolites; a significant proportion is excreted in the faeces.

Pizotifen Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Pizotifen Suppliers

Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Fax
001-617-206-9595
Email
sales@chemreagents.com
Country
United States
ProdList
10186
Advantage
62
LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
Alfa Chemistry
Tel
1-516-6625404
Fax
1-516-927-0118
Email
support@alfa-chemistry.com
Country
United States
ProdList
9171
Advantage
60
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32161
Advantage
58
Alfa Chemistry
Tel
Fax
1-516-927-0118
Email
Info@alfa-chemistry.com
Country
United States
ProdList
24072
Advantage
58
TargetMol Chemicals Inc.
Tel
Email
support@targetmol.com
Country
United States
ProdList
38631
Advantage
58
Aladdin Scientific
Tel
+1-+1(833)-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
OChem Incorporation
Tel
--
Fax
--
Email
sales@ocheminc.com
Country
United States
ProdList
6501
Advantage
60
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
MedChemExpress
Tel
--
Fax
--
Email
sales@medchemexpress.com
Country
United States
ProdList
6398
Advantage
58
Combi-Blocks Inc.
Tel
--
Fax
--
Email
sales@combi-blocks.com
Country
United States
ProdList
6618
Advantage
69
Riedel-de Haen AG
Tel
--
Fax
--
Country
United States
ProdList
6773
Advantage
87
TCI America
Tel
--
Fax
--
Email
sales@tciamerica.com
Country
United States
ProdList
6909
Advantage
75
SynFine Research
Tel
--
Fax
--
Email
research@synfine.com
Country
United States
ProdList
1024
Advantage
68
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6962
Advantage
56
AlliChem, LLC
Tel
--
Fax
--
Email
sales@allichemllc.com
Country
United States
ProdList
6516
Advantage
60
Waterstone Technology, LLC
Tel
--
Fax
--
Email
sales@waterstonetech.com
Country
United States
ProdList
6786
Advantage
30
3B Scientific Corporation
Tel
--
Fax
--
Email
sales@3bsc.com
Country
United States
ProdList
6718
Advantage
47
APAC Pharmaceutical, LLC
Tel
--
Fax
--
Email
sales@apacpharma.com
Country
United States
ProdList
6322
Advantage
38
AvaChem Scientific LLC
Tel
--
Fax
--
Email
Info@avachem.com
Country
United States
ProdList
315
Advantage
30
AK Scientific, Inc.
Tel
--
Fax
--
Email
sales@aksci.com
Country
United States
ProdList
6347
Advantage
65
BOSCHE SCIENTIFIC, LLC
Tel
--
Fax
--
Email
Sales@BoscheSci.com
Country
United States
ProdList
6477
Advantage
55
ChemPacific Corporation
Tel
--
Fax
--
Email
sales@chempacific.com
Country
United States
ProdList
6891
Advantage
51
More
Less

View Lastest Price from Pizotifen manufacturers

Baoji Guokang Bio-Technology Co., Ltd.
Product
Pizotifen 15574-96-6
Price
US $4603.00/g
Min. Order
100g
Purity
99%
Supply Ability
100kg
Release date
2021-06-04
Hebei Weibang Biotechnology Co., Ltd
Product
Pizotifen 15574-96-6
Price
US $10.00/PCS
Min. Order
1KG
Purity
99%
Supply Ability
10 mt
Release date
2021-03-12
WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
Product
Pizotifen 15574-96-6
Price
US $0.00/KG
Min. Order
100g
Purity
98%+
Supply Ability
100kg
Release date
2020-09-27

15574-96-6, PizotifenRelated Search:


  • Pizotylene
  • PIZOTHIFENUM
  • Pizotifenum
  • Pizotyline (base and/or unspecified salts)
  • 4-OXO-9,10-DIHYDRO-4H-BENZO(4,5) CYCLOHEPTO(1,2,B) THIOPHENE
  • PIZOTIFEN
  • 4-(9,10-Dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thien-4-ylidene)-1-methylpiperidine
  • BC 105
  • bc105
  • Litec
  • Piperidine, 4-(9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thien-4-ylidene)-1-methyl-
  • piperidine,4-(9,10-dihydro-4h-benzo(4,5)cyclohepta(1,2-b)thien-4-ylidene)-1-me
  • Pizotifan
  • Pizotyline
  • Pizotyline maleate
  • Sandomigram
  • Sandomigran
  • Sandomygran
  • 4-(9,10-dihydro-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methylpiperidine
  • Pizotifen USP/EP/BP
  • 4-(4,5-dihydrobenzo[1,2]cyclohepta[3,4-b]thiophen-10-ylidene)-1-methylpiperidine
  • Pizotyline-D3
  • 15574-96-6
  • 574-96-6
  • C19H21NS
  • Aromatics
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
  • Sulfur & Selenium Compounds
  • Sandomigran, pizotyline
  • Pizotifen
  • Active Pharmaceutical Ingredients